SCHEMBL30520753

SCHEMBL30520753

O=C1c2ccccc2C(F)C(=O)N1CCOCCOCC(=O)N(Cc1ccc(F)cc1)c1ccc([N+](=O)[O-])c2nonc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 3/20 0.34
▸ TDO2 P48775 2/20 0.34
▸ MYC P01106 4/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ KCNH2 Q12809 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ DRD2 P14416 1/20 0.31
▸ DRD1 P21728 1/20 0.31
▸ SLC5A2 P31639 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ ALOX12 P18054 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25342557 1.00 IDO1 (0.34) IDO1TDO2MYCMEN1KMT2A
SCHEMBL25342697 0.93 GSTP1 (0.38) IDO1MYCMEN1KMT2AKDM4E
SCHEMBL30521150 0.92 RXFP1 (0.36) IDO1MYCMEN1KMT2AKCNH2
SCHEMBL25343604 0.92 RXFP1 (0.36) IDO1MYCMEN1KMT2AKCNH2
SCHEMBL30520813 0.90 FFAR1 (0.33) IDO1TDO2MYCMEN1KMT2A
SCHEMBL25342028 0.90 FFAR1 (0.33) IDO1TDO2MYCMEN1KMT2A
SCHEMBL30520833 0.89 MYC (0.35) IDO1TDO2MYCMEN1KMT2A
SCHEMBL25342114 0.89 MYC (0.35) IDO1TDO2MYCMEN1KMT2A
SCHEMBL25342713 0.87 MYC (0.35) IDO1TDO2MYCKCNH2DPP4
SCHEMBL30520943 0.87 MYC (0.35) IDO1TDO2MYCKCNH2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023143494-A1 NEW PROTAC COMPOUND 甘李药业股份有限公司 2023-08-03 — — WO disclosed
Send feedback